Children's Hospital Pittsburgh doctors at Cardiac World Congress; Only US doctors to present in Spanish

September 16, 2005

PITTSBURGH - Sept. 16, 2005 - Several Children's Hospital of Pittsburgh physicians will be presenting at the Fourth World Congress of Pediatric Cardiology and Cardiac Surgery this year, and will be the only group from the United States presenting in Spanish.

The physicians from Children's Hospital of Pittsburgh who are presenting at the world congress are: Victor Morell, MD, chief of the Division of Pediatric Cardiothoracic Surgery; Ricardo Munoz, MD, chief of Children's Cardiac Intensive Care; and Jacqueline Kreutzer, MD, director of Children's Interventional Cardiology.

The Fourth World Congress of Pediatric Cardiology and Cardiac Surgery (WCPCCS) brings together world-renowned pediatric cardiovascular health professionals and experts to discuss key issues around cardiovascular science. The WCPCCS is held every four years and will be held this year in Buenos Aires, Argentina.

This congress will bring in more than 2,500 delegates including physicians, researchers, scientists, nurses, technicians, policy makers, and others who are involved in pediatric cardiovascular medicine and health care. Dr. Morell will present on cardiac transplantation for the management of hypoplastic left heart syndrome, while Dr. Munoz will speak on pre-operative management of hypoplastic heart syndrome.

Hypoplastic left heart syndrome is a combination of several abnormalities of the heart and great blood vessels. It is a congenital (present at birth) syndrome, meaning that the heart defects occur due to abnormal underdevelopment of sections of the fetal heart during the first eight weeks of pregnancy. Hypoplastic left heart syndrome can be fatal without treatment.

Dr. Kreutzer will discuss cardiac cauterization interventional procedures for patients with single ventricle. While the normal heart has two ventricles, in some birth defects, one of these ventricles may be absent or poorly developed. This condition is called single ventricle, which connects with the aorta and pulmonary artery.

"It is an honor for us to be asked to speak at this world congress and highlight the advancements, surgical accomplishments and expertise of our cardiac team at Children's," said Dr. Morell, who was the lead doctor involved in an uncommon surgical procedure implanting a Berlin Heart, which is an experimental, child-size artificial heart pump that keeps young patients alive while awaiting a heart transplant.

The pediatric Berlin Heart has been used in the United States only on a very limited basis; in each case with emergency approval from the Food and Drug Administration.

Fewer than two dozen of these cases have been done in the United States, with Children's performing four of them.

Dr. Morell, who also is an associate professor of Surgery at the University of Pittsburgh School of Medicine, is co-investigator of a National Institutes of Health-funded research initiative to develop an implantable ventricular assist device suitable for use in infants and children. He also is involved in clinical studies related to pediatric cardiothoracic surgery with expertise in the management of complex transposition of the great arteries with a ventricular septal defect and pulmonary stenosis.

The four-day program includes seven sessions that will provide overviews of new and exciting developments in the field of pediatric cardiology and surgery. The program also includes 20 topics meant to elicit lively debates, and 48 symposiums to allow an in-depth discussion of most aspects of pediatric cardiology and pediatric cardiovascular surgery.

For a hospital where heart defects are repaired in children only a few months old; toddlers are transplant candidates; and children are sustained for weeks or months on mechanical heart pumps, Children's CICU provides the level of post-surgical medical care young cardiac patients need, said Dr. Munoz. With access to the latest technology, doctors can operate on the spot and are able to isolate patients who have recently received heart transplants and are in need of immunosuppressive drugs.

"Being able to share our experience and expertise with others in the medical profession in such a setting is truly an honor," said Dr. Munoz, who also is an assistant professor of Critical Care Medicine, Pediatrics and Pediatric Cardiology at the University of Pittsburgh School of Medicine. "Our CICU and team of specialized doctors, nurses and staff have been given countless opportunities in the treatment of children in this region and well beyond."
For more information about Children's Heart Center, physicians and more, please visit

Children's Hospital of Pittsburgh

Related Cardiac Surgery Articles from Brightsurf:

New surgical tools with smart sensors can advance cardiac surgery and therapy
Researchers developed a new class of medical instruments equipped with an advanced soft electronics system that could dramatically improve the diagnoses and treatments of a number of cardiac diseases and conditions.

How commonly do patients develop persistent opioid use after cardiac surgery?
A large, national database was used to determine how common it was for patients who hadn't used opioids before undergoing a coronary artery bypass grafting or heart valve procedure to subsequently develop persistent opioid use after surgery.

Preoperative levels of heart proteins may help predict death or cardiac complications in patients undergoing noncardiac surgery
Assessing preoperative levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), a biomarker of heart stress and structural changes, may improve risk prediction beyond the clinical risk score in patients having noncardiac surgery.

Study finds connection between cardiac blood test before surgery and adverse outcomes
The VISION study looked at whether levels of a cardiac blood test, NT-proBNP, measured before surgery can predict cardiac and vascular complications.

Mayo Clinic study: 20% of patients are prescribed opioids after cardiac device implantation surgery
One in five patients is prescribed opioids after having a pacemaker or similar device implanted, according to a large US study conducted at Mayo Clinic published in HeartRhythm.

Careful monitoring of children following cardiac surgery may improve long-term outcomes
In a medical records study covering thousands of children, a US-Canadian team led by researchers at Johns Hopkins Medicine concludes that while surgery to correct congenital heart disease (CHD) within 10 years after birth may restore young hearts to healthy function.

Chest cavity fire during emergency cardiac surgery
At this year's Euroanaesthesia Congress (the annual meeting of the European Society of Anaesthesiology) in Vienna, Austria (1-3 June), doctors present the unique case of a man who suffered a flash fire in his chest cavity during emergency heart surgery caused by supplemental oxygen leaking from a ruptured lung.

Steroid use during cardiac bypass surgery did not reduce risk of severe kidney injury
Using steroids during cardiopulmonary bypass surgery did not reduce the risk of acute kidney injury in people at increased risk of death, according to a study conducted in 18 countries published in CMAJ (Canadian Medical Association Journal).

Cardiac surgery for patients with persistent opioid use associated with higher rate of complications, increased costs
Persistent use of opioids by patients is a public health concern in the United States but not much is known about the effect of that use on patients undergoing cardiac surgery.

Blood thinner significantly reduces the risk of death after non-cardiac surgery
The study enrolled 1,754 patients in 19 countries, 51 percent of whom were male, with an average age of 70 years.

Read More: Cardiac Surgery News and Cardiac Surgery Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to